Ca2+ signaling in human induced pluripotent stem cell-derived cardiomyocytes (iPS-CM) from normal and catecholaminergic polymorphic ventricular tachycardia (CPVT)-afflicted subjects
Ca2+ signaling in human induced pluripotent stem cell-derived cardiomyocytes (iPS-CM) from normal and catecholaminergic polymorphic ventricular tachycardia (CPVT)-afflicted subjects
复制标题
DOI:
10.1016/j.ceca.2013.04.004
复制
发表时间:
2013-08-01
期刊:
影响因子:
4
通讯作者:
Morad, M.
中科院分区:
文献类型:
--
作者:
Zhang, X. -H.;Haviland, S.;Morad, M.
Derivation of cardiomyocytes from induced pluripotent stem cells (iPS-CMs) allowed us to probe the Ca2+-signaling parameters of human iPS-CMs from healthy- and catecholaminergic polymorphic ventricular tachycardia (CPVT1)-afflicted individuals carrying a novel point mutation p.F2483I in ryanodine receptors (RyR2). iPS-CMs were dissociated on day 30-40 of differentiation and patch-clamped within 3-6 days. Calcium currents (I-Ca) averaged similar to 8 pA/pF in control and mutant iPS-CMs. I-Ca-induced Ca2+-transients in control and mutant cells had bell-shaped voltage-dependence similar to that of I-Ca, consistent with Ca2+-induced Ca2+-release (CICR) mechanism. The ratio of I-Ca -actiyated to caffeine-triggered Ca2+-transients was similar to 0.3 in both cell types. Caffeine-induced Ca2+-transients generated significantly smaller Na+-Ca2+ exchanger current (I-NCX) in mutant cells, reflecting their smaller Ca2+-stores. The gain of CICR was voltage-dependent as in adult cardiomyocytes. Adrenergic agonists enhanced I-Ca, but differentially altered the CICR gain, diastolic Ca2+, and Ca2+-sparks in mutant cells. The mutant cells, when Ca2+-overloaded, showed longer and wandering Ca2+-sparks that activated adjoining release sites, had larger CICR gain at -30 mV yet smaller Ca2+-stores. We conclude that control and mutant iPS-CMs express the adult cardiomyocyte Ca2+-signaling phenotype. RyR2 F2483I mutant myocytes have aberrant unitary Ca2+-signaling, smaller Ca2+-stores, higher CICR gains, and sensitized adrenergic regulation, consistent with functionally altered Ca2+-release profile of CPVT syndrome. (C) 2013 Elsevier Ltd. All rights reserved.